486-25550-63868
3 vaccinations
1 coded response
6 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 494 / MI
- Registered
- 2021-02-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
93Y-12853-32457
Child or adolescent in my care · Male · 2022-04-23
UDM-41867-36414
Child or adolescent in my care · Female · 2022-04-23
P4Y-75906-29329
Child or adolescent in my care · Female · 2022-04-23
Timeline
-
2021-01-28
Dose 1 — Pfizer-BioNTech
-
2021-02-18
Dose 2 — Pfizer-BioNTech
-
2021-02-19
Registered in v-safe
-
2021-02-19
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-08-19
-
2021-10-01
Dose 3 — Pfizer-BioNTech
-
2022-02-18
Survey response — 12 months, dose 2MedDRA: Malaise, Sinusitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Almost every COVID symptom Sinus infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-02-18
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-02-21
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-28 | Pfizer-BioNTech | |
| 2 | 2021-02-18 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-18 | Successful 2022-02-21 |
Participant prefers to complete VAERS report online |
Free text
Release 11 — 12 months, dose 2
Symptoms: Almost every COVID symptom Sinus infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Malaise | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release